Market Research > Healthcare > Rx-to-OTC Switch Series

Market Research Reports: Rx-to-OTC Switch

Rx-to-OTC Switch Forecasts USA: Next Frontier
Published August 2017
Base Year: 2017
Forecasts to 2022

Download Brochure Price & Ordering

  • Description
  • Regional Coverage: United States

    This report provides subscribers with a comprehensive, objective assessment of the Rx-to-OTC switch landscape including forecasts of future switches in the United States. This report provides forecasts of switches in existing OTC categories and projections for new OTC categories. The study provides a broad assessment of “switchable” OTC categories, a specific analysis and forecasts of most likely switch categories and drugs, and an analysis of regulatory and retail paradigm shifts and implications for future switches.

    This Report Helps Subscribers to:

    • Assess Rx-to-OTC switch forecasts by category
    • Analyze regulatory and retail paradigm shifts and implications for future switches
    • Cast a wide-net analysis for uncovering potential licensing opportunities
    • Specific analysis and forecasts of the most likely switch drugs/categories
  • Contents
  • Introduction

    Executive Summary
    Overview of key findings and trends

    • Regulatory considerations for switches
    • Recent switches
    • Switch forecasts
    • Competitive landscape
    • Conclusion and appraisal
    Switch Forecasts by Category
    For each of the categories shown in Table 1, the following information is provided:

    • Comparative analysis of Rx and OTC markets (where applicable)
    • Regulatory considerations
    • Safety/efficacy
    • Patent status
    • Potential nonprescription drugs claims
    • Likelihood of switch and expected timing
    • OTC sales forecasts
    • Expected competitive response from both branded and private-label products
    FutureView Forecasting Model
    This report includes access to Kline’s proprietary and interactive FutureView forecasting model, which is an Excel-based model accessed online. The model provides Kline’s assumptions about the probability of switch and sales forecasts by brand and therapeutic class. The assumptions in the model can be changed by users to revise sales forecasts or probabilities for classes/drugs included in this analysis or for other classes/drugs not profiled.

    Table 1: List of Categories Analyzed
    Benign prostatic hyperplasia
    Digestive products
    Erectile dysfunction
    Overactive bladder
    Sleeping aids
    Skin rash/eczema psoriasis
    Topical pain relievers

    Kline’s FutureView Forecasting Model
    Rx-to-OTC Switch Forecasting Model
  • Scope
  • Rx-to-OTC Switch Forecasts USA: Next Frontier represents the 12th edition in Kline’s venerable series of reports on Rx-to-OTC switches. With this study, we uncover opportunities for future switches in the U.S. market. This study will attempt to understand how shifts in regulations, retail environment, and technology may have significant impacts on future switches. This report covers the U.S. market for Rx-to-OTC switches and provide sales forecasts through 2022. Full subscribers to this report are entitled to access to Kline’s proprietary FutureView Forecasting Model, which helps predict the likelihood of switches, as well as sales forecasts for switch brands and categories.

  • Key Benefits
  • For consumer health marketers, Rx-to-OTC Switch Forecasts USA: Next Frontier examines the key issues and implications that switches can have on existing OTC businesses and identify opportunities for future growth from switches. Accurately predicting Rx-to-OTC switches and assessing their impact is crucial for maximizing business opportunities, minimizing threats, and successfully constructing long-term strategic plans. Specifically, the report provides subscribers with the following key deliverables:

    • Up-to-date primary research on switches conducted with knowledgeable industry participants
    • Casts a wide-net analysis to uncover potential licensing opportunities
    • Realistic assessment of regulatory climate and future implications
    • An understanding of implications of future switches on existing OTC categories
    • Identification of future opportunities by identifying categories with high likelihood of switch, and forecasting sales potential and likely timing
  • Methodology
  • Kline’s approach places the principal emphasis on primary research techniques to ensure that the foundation of business intelligence and insight is accurate, current, and reliable. Building on our 50-plus years in the business and leveraging our worldwide network of offices, our teams of seasoned professionals draw upon pragmatic industrial and commercial experience to understand and interpret global impacts and local perspectives.

    Primary Research
    We Know Who to Talk to. We Know How to Listen.

    A high number of in-depth discussions are conducted by each analyst. All interviews are done with true industry insiders.

    Kline’s analysts draw upon pragmatic experience to understand global impacts and local perspectives. Our interviews engage experts across all pertinent fields and sectors including:

    • Prescription drug executives
    • OTC drug executives
    • Regulators
    • Retailers
    • Pharmacists
    • Patent attorneys
    • Industry consultants
    • Trade associations

    Secondary Research
    We Know Where to Look – Mining the Details.

    Analysis is further supplemented by secondary research, consisting of constant tracking of annual company reports, national statistics bureaux, trade/ industrial/professional associations and the like.

    Relevant developments are diligently followed and their impact closely monitored. Reports also draw upon non-confidential data from Kline’s internal database, consisting of over half a century’s syndicated research.

    Comprehensive Market Intelligence
    We Know How to Verify.

    Data are rigorously analyzed, cross-checked, distilled and validated. Kline’s proven methodology allows exceptionally effective, precise and reliable market intelligence procurement and assessment, giving subscribers a solid foundation on which to grow, refine and expand their business with confidence.

    Kline Credentials

    Kline is a leading global management consulting and market research firm offering the complete spectrum of services. The firm has served the management consulting and market research needs of organizations in the chemicals, materials, energy, life sciences, and consumer products industries for over 50 years.

Share this: Email This Page

Related Reports
Nonprescription Drugs USA
Rx-to-OTC Switch Pipelines
50 Years of OTC Research
An evolution of the U.S. OTC market since 1963 >>

Industry Expert

Laura Mahecha   Laura Mahecha

Sales Contacts

Pilar Pardo   Pilar Pardo
Kristy Altenburg   Kristy Altenburg
Contact Kline Market Research   View all contacts
Market Research Reports   Purchase a Report
  Healthcare Portfolio
  Knowledge Hub
Custom Research
Can’t find exactly what you’re looking for? Consider a custom report.